Although COVID cases are steadily decreasing, new COVID variants continue to emerge, posing unique challenges to global health efforts. A new omicron subvariant, Arcturus – named after the constellation – is a newly identified strain of the SARS-CoV-2 virus that causes COVID-19. 

According to the CDC, Arcturus is responsible for more than 9% of COVID cases nationwide as of April, 2023. Officials state that the strain is causing high fevers and conjunctivitis – also known as pink eye – particularly in children.  

At this early stage, scientific studies are underway to determine the transmissibility and severity of the Arcturus variant. Preliminary data suggest that it may have an increased ability to spread between individuals compared to previous variants. At the current time, there is no evidence to suggest that Arcturus is more dangerous than the other Omicron variants currently in circulation.  

More research is needed to fully understand its potential impact on public health, including its resistance to existing vaccines and the effectiveness of current treatment protocols. Vaccination remains a crucial tool in reducing the severity of COVID-19 and curbing its transmission, including against emerging variants like Arcturus. It is vital for individuals to get vaccinated when eligible and to follow local guidelines regarding mask-wearing, social distancing, and hand hygiene. 

As we navigate the evolving landscape of COVID-19, it is essential for individuals to stay vigilant and informed about the latest developments. Following credible sources of information such as the World Health Organization (WHO) and local health authorities can help individuals stay updated on the Arcturus variant and any recommendations or guidelines specific to their region. 

Sources:  

Berger, E. (2023, May 9). Covid officials say new “Arcturus” variant could be linked to conjunctivitis. The Guardian. https://www.theguardian.com/world/2023/may/09/covid-variant-arcturus-conjunctivitis